We have used homologous recombination in embryonic stem (ES) cells to investigate the effects of the DNA ligase IV null mutation in the mouse. A lambda phage clone containing the LIG4 gene was isolated from a mouse 129SV genomic library (Figure 1a) . Partial DNA sequencing of the genomic clone revealed that the mouse LIG4 gene does not contain any introns. Amino acids 205-521, which define the highly conserved catalytic domain of the protein [1] , are 91% identical between mouse and man; the corresponding region of the human DNA ligase I coding sequence is interrupted by nine introns of average size 1.9 kb [15] . The DNA sequence encoding amino acids 142-685 of the 911-residue DNA ligase IV [10] was replaced in the targeting construct (Figure 1b,c) .
Results and discussion
We have used homologous recombination in embryonic stem (ES) cells to investigate the effects of the DNA ligase IV null mutation in the mouse. A lambda phage clone containing the LIG4 gene was isolated from a mouse 129SV genomic library ( Figure 1a ). Partial DNA sequencing of the genomic clone revealed that the mouse LIG4 gene does not contain any introns. Amino acids 205-521, which define the highly conserved catalytic domain of the protein [1] , are 91% identical between mouse and man; the corresponding region of the human DNA ligase I coding sequence is interrupted by nine introns of average size 1.9 kb [15] . The DNA sequence encoding amino acids 142-685 of the 911-residue DNA ligase IV [10] was replaced in the targeting construct (Figure 1b,c) .
G418-resistant clones arising from transfection of ES cells with the targeting construct were screened for homologous recombination at one allele of the LIG4 locus (Figure 1d ). Two independent ES clones (one from each of two substrains of 129SV ES cells [16] ) were injected into C57BL/6J blastocysts to generate germline chimaeras and lig4 mutant mice and gave analogous results in all subsequent experiments (Table 1) . Mice heterozygous for the targeted lig4 gene disruption were established from germline chimaeras and these were phenotypically normal up to 9 months of age. When F1 heterozygotes were interbred, however, no offspring homozygous for the lig4 mutation were detected in F2 litters. Cumulative genotyping of 104 liveborn mice from heterozygous intercrosses indicated that lig4 +/-and wild-type mice were recovered at a ratio close to 2:1 (Table 1) . Staged heterozygote matings were analysed at embryonic stage E9.5 (days post-coitum; Figure 1e ) and lig4 -/-embryos were recovered at frequencies consistent with Mendelian segregation; these embryos were visually indistinguishable from their wildtype and heterozygous siblings. Live lig4 -/-embryos were still detected at E13.5 but not at E16.5 (Table 2) . These results indicate an essential function for the LIG4 gene that results in a loss of viability two-thirds of the way through mouse embryogenesis.
Histopathological examination of E13.5 lig4 -/-embryos showed normal morphology of most organs. In each of four lig4 -/-E13.5 embryos from two different litters, however, regions of the central nervous system (CNS) showed abnormal pathology, with extensive apoptotic cell death (Figures 2,3) . Some apoptosis was also observed in the spleen, at a higher level than in control embryos. In the brain, apoptosis was most marked in the midbrain, around the pons and the medulla, and also in the thalamus, hypothalamus and striatum, with clusters of apoptotic cells and loss of neurons leading to hypocellular regions. Intriguingly, the apoptotic clusters were symmetrical, clearly affecting corresponding areas (Figure 3a,c) . There was extensive apoptosis in the mantle layer of the spinal cord, but considerably less in the ependymal and marginal layers.
The olfactory lobes and epithelium appeared relatively unaffected, as were the choroid plexus and meninges. Focal apoptosis was seen in the peripheral zone of the neopallial cortex, and also in the trigeminal ganglion and other paravertebral ganglia. Five wild-type and heterozygous siblings showed essentially normal development.
In S. cerevisiae, in contrast to mammalian cells, NHEJ is a minor pathway for the repair of DNA double-strand breaks. Yeast lig4-null mutants are deficient in NHEJ but are viable [8] [9] [10] , having a similar phenotype to mutants of the recently discovered XRCC4 homologue, LIF1 [17] . One of the major functions of the XRCC4 homologue in yeast appears to be stabilisation of DNA ligase IV, so one would expect both XRCC4 and DNA ligase IV function to be affected in an xrcc4 knockout mouse [17] . Recently, Alt and coworkers [18] have obtained knockout mice defective in DNA ligase IV. This group independently observed the embryonic lethal phenotype, and cell lines derived from null embryos were deficient in V(D)J joining and hypersensitive to ionising radiation [18] ; this phenotype is very similar to that previously observed for human xrcc4-mutant cells.
As reported for DNA-PKcs [19] , and possibly indicative of differences in NHEJ between rodent and human cells [20] , DNA ligase IV and XRCC4 seem to be present at extremely low levels in murine cell extracts and are not readily detected by immunoblotting with various antisera raised against the human proteins (R.P. Bowater and D.E.B., unpublished observations). DNA ligase IV could be detected in extracts from normal E13.5 mouse embryos, however, by formation of a 32 P-labelled enzyme-AMP intermediate following co-immunoprecipitation with antibodies against full-length recombinant human XRCC4 [4] . As observed previously, most of the DNA ligase IV was apparently adenylated in vivo, so radiolabelled enzyme-AMP was detected only following the discharging of pre-formed complexes by incubation of the co-immunoprecipitate with pyrophosphate [2] . No DNA Table 1 Genotyping of liveborn progeny from intercrosses of heterozygous lig4 mice. ligase IV activity was detected in E13.5 lig4-null embryos (Figure 1f ).
DNA ligase IV is implicated in NHEJ in mammalian cells [4, 5] and carries out the ligation step of NHEJ in vitro [20, 21] . Mutant mammalian cell lines deficient in the XRCC4, Ku70, Ku80 or DNA-PKcs components of the NHEJ pathway are also defective in V(D)J recombination (reviewed in [7] ). Of the gene products proposed to act in NHEJ in mammalian cells, only DNA ligase IV has not been represented amongst previously described mutant cell lines [22] . Here, genetic studies of this enzyme in mammalian cells were initiated by targeted disruption of the gene encoding DNA ligase IV in mice. Unlike null mutations affecting other components of the NHEJ pathway, such as DNA-PKcs and Ku70/80 [11] [12] [13] [14] , the lig4-null mutation leads to embryonic lethality in the mouse. The possibility that this phenotype could be ascribed to the loss of a different overlapping gene is highly unlikely but cannot at present be excluded. Future analyses will aim to determine the unanticipated essential function of DNA ligase IV that is limiting during differentiation of the embryonic CNS. Murine lig4-null cells may exhibit an inadequate response to growth regulatory signals, as described for the yeast lig4 mutant [17] , and this defect might have particularly severe consequences in developing neural tissue. Alternatively, the high level of
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Figure 2
Abnormal CNS development in lig4-null embryos. oxygen metabolism in the brain might lead to the formation of reactive oxygen species that generate endogenous DNA double-strand breaks at a higher frequency than in other organs, and DNA ligase IV may be required to repair such damage. The murine DNA ligase IV null phenotype may also be relevant to a possible role of somatic DNA recombination in the development of the CNS [23] .
Materials and methods
Construction of the lig4 targeting vector
A partial murine cDNA clone encoding the catalytic domain of DNA ligase IV was isolated by reverse transcription PCR and used to screen a mouse 129SV genomic library in λ2001 [24] using standard techniques. A genomic clone (~17 kb) was mapped for the restriction enzymes shown in Figure 1 , a ~1 kb HindIII fragment was identified as containing the active site of the enzyme by hybridisation with a specific oligonucleotide probe, and the entire DNA ligase IV open reading frame was sequenced. A ~5.5 kb HindIII fragment 5′ to the active site was cloned into the BamHI site of pSK-MC1-NEO-polyA [25] and ã 3.2 kb BamHI-EcoRI 3′ fragment was cloned into the XhoI site by means of double-stranded oligonucleotide linkers; HindIII and XhoI sites were not regenerated during this process (Figure 1 ). The targeting construct was verified by restriction enzyme digest and DNA sequencing, and propagated in the SURE Escherichia coli strain (Stratagene).
Generation of lig4-mutant mice
NotI-linearised targeting vector was electroporated into GK129 or RI ES cells [16] from 129SV mice and selected as described previously [25] . G418-resistant colonies were transferred into duplicate 96-well plates. Genomic DNA was isolated from one set of plates, digested with BamHI and analysed by Southern hybridisation analysis (Figure 1d) . ES clones in which homologous recombination had occurred in one allele of the LIG4 gene were expanded from duplicate plates and injected into blastocysts from C57BL/6J mice [25] . Resultant chimaeras were mated, and agouti F1 progeny screened by tail biopsy. Mice heterozygous for the targeted lig4 allele were interbred and F2 progeny genotyped as above.
Analysis of lig4 embryos
Post-implantation embryos were explanted from pregnant females following staged heterozygous matings, with E0.5 corresponding to detection of a vaginal plug. Genotyping of embryos was carried out by PCR amplification of DNA from the microdissected yolk sac after boiling for 10 min in 20-100 µl distilled water. NEO and LIG4 gene-specific primers (30-mers) were located as shown in Figure 1 . PCR amplification of genomic DNA was carried out for 30 cycles with primers F1, N1 and R1, and one-tenth of the PCR product was further amplified for 30 cycles with nested primers F2, N2 and R2, producing a 1.6 kb fragment from the wild-type allele and a 1.1 kb fragment from the targeted allele, which were resolved by ethidium bromide/agarose gel electrophoresis. Microdissected embryos were fixed in 10% saline formalin, embedded in paraffin, and sections stained with haematoxylin and eosin. Apoptotic regions were identified using the ApopTag kit (Oncor, Gaithersberg, MD), essentially as described by the manufacturer but omitting the proteinase K step. Extracts were prepared by macerating embryos in lysis buffer, and immunoprecipitation and enzyme adenylation were carried out as described previously [26] . SJ4 antiserum against XRCC4 was provided by S. Jackson (Wellcome-CRC Institute, Cambridge, UK).
